Here you can find news from MPG spin-off companies.
Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy
MODAG Initiates First-in-Patient Phase 1b Trial for Anle138b in Parkinson´s Disease
Evotec and Rappta Therapeutics enter discovery and development partnership focused on oncology target
Alnylam Announces FDA Approval of OXLUMO™ (lumasiran) for treating Primary Hyperoxaluria Type 1
Cardior announces positive results of its phase Ib study of the active ingredient CDR132L for the treatment of cardiovascular diseases.